File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tenoxicam for pain relief following third molar surgery.

TitleTenoxicam for pain relief following third molar surgery.
Authors
Issue Date1992
Citation
Anesthesia & Pain Control In Dentistry, 1992, v. 1 n. 4, p. 229-233 How to Cite?
AbstractTenoxicam is a long-acting nonsteroidal anti-inflammatory agent that appears to have the ability to control pain of musculoskeletal origin. A double-blind randomized crossover study was designed to determine the efficacy of tenoxicam for pain relief following third molar surgery by comparing it with paracetamol. Immediately before surgery, 30 Chinese patients with bilateral symmetrically impacted mandibular third molars were given 40 mg of tenoxicam for surgery on one side and 1,000 mg of paracetamol for surgery on the other. Both paracetamol and tenoxicam were efficient as pain relievers after third molar surgery. Tenoxicam had comparable efficacy to paracetamol, but did not provide any advantage in terms of duration of action. The discrepancy between the clinical observation and pharmacokinetic prediction may be related to the strong serum binding property of tenoxicam.
Persistent Identifierhttp://hdl.handle.net/10722/153796
ISSN

 

DC FieldValueLanguage
dc.contributor.authorCheung, LKen_US
dc.contributor.authorRodrigo, Cen_US
dc.date.accessioned2012-08-08T08:21:37Z-
dc.date.available2012-08-08T08:21:37Z-
dc.date.issued1992en_US
dc.identifier.citationAnesthesia & Pain Control In Dentistry, 1992, v. 1 n. 4, p. 229-233en_US
dc.identifier.issn1055-7601en_US
dc.identifier.urihttp://hdl.handle.net/10722/153796-
dc.description.abstractTenoxicam is a long-acting nonsteroidal anti-inflammatory agent that appears to have the ability to control pain of musculoskeletal origin. A double-blind randomized crossover study was designed to determine the efficacy of tenoxicam for pain relief following third molar surgery by comparing it with paracetamol. Immediately before surgery, 30 Chinese patients with bilateral symmetrically impacted mandibular third molars were given 40 mg of tenoxicam for surgery on one side and 1,000 mg of paracetamol for surgery on the other. Both paracetamol and tenoxicam were efficient as pain relievers after third molar surgery. Tenoxicam had comparable efficacy to paracetamol, but did not provide any advantage in terms of duration of action. The discrepancy between the clinical observation and pharmacokinetic prediction may be related to the strong serum binding property of tenoxicam.en_US
dc.languageengen_US
dc.relation.ispartofAnesthesia & pain control in dentistryen_US
dc.subject.meshAcetaminophen - Therapeutic Useen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal - Therapeutic Useen_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMandibleen_US
dc.subject.meshMolar, Third - Surgeryen_US
dc.subject.meshPain, Postoperative - Drug Therapyen_US
dc.subject.meshPiroxicam - Analogs & Derivatives - Therapeutic Useen_US
dc.subject.meshTooth Extractionen_US
dc.subject.meshTooth, Impacted - Surgeryen_US
dc.titleTenoxicam for pain relief following third molar surgery.en_US
dc.typeArticleen_US
dc.identifier.emailCheung, LK:lkcheung@hkucc.hku.hken_US
dc.identifier.authorityCheung, LK=rp00013en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid1298491-
dc.identifier.scopuseid_2-s2.0-0026922550en_US
dc.identifier.volume1en_US
dc.identifier.issue4en_US
dc.identifier.spage229en_US
dc.identifier.epage233en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridCheung, LK=7102302747en_US
dc.identifier.scopusauthoridRodrigo, C=7006322897en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats